Unique Ultrastructure of Exorbital Lacrimal Glands in Male NOD and BALB/c Mice

REFERENCES

• Goillot E, Mutin M, Touraine J L. Sialadenitis in nonobese diabetic mice: transfer into syngeneic healthy neonates by splenic T lymphocytes. Clin Immunol Immunopathol. 2001; 59: 462–473, [CSA]
   Google Scholar
• Robinson C P, Yamachika S, Alford C E, et al. Elevated levels of cysteine protease activity in saliva and salivary glands of the nonobese diabetic (NOD) mouse model for Sjögren's syndrome. Proc Nat Acad Sci USA. 1997; 94: 5767–5771, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Tornwall J, Lane T E, Fox R I, Fox H S. T cell attractant chemokine expression initiates lacrimal gland destruction in nonobese diabetic mice. Lab Invest. 1999; 79: 1719–1726, [CSA]
   PubMed Web of Science ®Google Scholar
• Hayashi Y, Arakaki R, Ishimaru N. The role of caspase cascade on the development of primary Sjögren's syndrome. J Med Invest. 2003; 50: 32–38, [CSA]
   PubMedGoogle Scholar
• Makino S, Kunimoto K, Muraoka Y, et al. Breeding of a non-obese, diabetic strain of mice. Exp Anim. 1980; 29: 1–8, [CSA]
   PubMedGoogle Scholar
• Brayer J, Lowry J, Cha S, et al. Alleles from chromosome 1 and 3 of NOD mice combine to influence Sjögren's syndrome-like autoimmune exocrinopathy. J Rheumatol. 2000; 27: 1896–1904, [CSA]
   PubMed Web of Science ®Google Scholar
• Hunger R E, Muller S, Laissue J A, et al. Inhibition of submandibular and lacrimal gland infiltration in nonobese diabetic mice by transgenic expression of soluble TNF-receptor p55. J Clin Invest. 1996; 98: 954–961, [CSA]
   PubMed Web of Science ®Google Scholar
• Hunger R E, Carnaud C, Vogt I, Mueller C. Male gonadal environment paradoxically promotes dacryoadenitis in nonobese diabetic mice. J Clin Invest. 1998; 101: 1300–1309, [CSA]
   PubMed Web of Science ®Google Scholar
• Esch T R, Poveromo J D, Aikens M C, Levanos V A. A novel lacrimal gland autoantigen in the NOD mouse model of Sjögren's syndrome. Scand J Immunol. 2002; 55: 304–310, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Wicker L S, Todd J A, Peterson L B. Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol. 1995; 13: 179–200, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Winer S, Astsaturov I, Cheung R, et al. Primary Sjögren's syndrome and deficiency of ICA69. Lancet. 2002; 360: 1063–1069, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Jabs D A, Lee B, Whittum-Hudson J A, Prendergast R A. Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice. Invest Ophthalmol Vis Sci. 2000; 41: 826–831, [CSA]
   PubMed Web of Science ®Google Scholar
• Hirai S, Ishida N, Watanabe K, Mita S. Leakage of aquaporin 5 in the tear of dacryoadenitis mice. Invest Ophthalmol Vis Sci. 2000; 41: 2432–2437, [CSA]
   PubMed Web of Science ®Google Scholar
• Ding C, Walcott B, Keyser K T. Neuronal nitric oxide synthase and the autonomic innervation of the mouse lacrimal gland. Invest Ophthalmol Vis Sci. 2001; 42: 2789–2794, [CSA]
   PubMed Web of Science ®Google Scholar
• Schechter J, Weiner R. Changes in basic fibroblast growth factor coincident with estradiol-induced hyperplasia of the anterior pituitaries of Fischer 344 and Sprague-Dawley rats. Endocrinology. 1991; 129: 2400–2408, [CSA]
   PubMed Web of Science ®Google Scholar
• da Costa S R, Wu K, Veigh M M, et al. Male NOD mouse external lacrimal glands exhibit profound changes in the exocytotic pathway early in postnatal development. Exp Eye Res. 2005; 7: 1–13, [CSA]
   Google Scholar
• Chomette G, Auriol M, Liotet S. Ultrastructural study of the lacrimal gland in a case of Sjögren's syndrome. Scand J Rheumatol. 1986; 61: 71–75, [CSA]
   Google Scholar
• Hagenfeldt-Johansson K A, Herrera P L, Wang H, et al. Beta-cell-targeted expression of a dominant-negative hepatocyte nuclear factor-1 alpha induces a maturity-onset diabetes of the young (MODY) 3-like phenotype in transgenic mice. Endocrinology. 2001; 142: 5311–5320, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Maciejewski R, Burski K, Burdan F, et al. Lipid and exocrine pancreatic ultrastructural changes due to experimental diabetes. Acta Physiol Hungarica. 2001; 88: 63–72, [CSA]
   PubMedGoogle Scholar
• Lee Y, Hirose H, Zhou Y T, et al. Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM. Diabetes. 1997; 46: 408–413, [CSA]
   PubMed Web of Science ®Google Scholar
• Zhou Y T, Shimabukuro M, Lee Y, et al. Enhanced de novo lipogenesis in the leptin-unresponsive pancreatic islets of prediabetic Zucker fatty rats: role in the pathogenesis of lipotoxic diabetes. Diabetes. 1998; 47: 1904–1908, [CSA]
   PubMed Web of Science ®Google Scholar
• Unger R H, Zhou Y T. Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. Diabetes. 2001; 50: S118–121, [CSA]
   PubMed Web of Science ®Google Scholar
• Chandrasoma P, Taylor C. Concise Pathology., et al. Appleton and Lange, Stamford 1998; 237–238
   Google Scholar
• Liscum L, Arnio E, Anthony H, et al. Identification of a pharmaceutical compound that partially corrects the Niemann-Pick C phenotype in cultured cells. J Lipid Res. 2002; 43: 1708–1717, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Yin D. Biochemical basis of lipofuscin, ceroid, and age pigment-like fluorophores. Free Radic Biol Med. 1996; 21: 871–888, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Suter M, Reme C, Grimm C, et al. Age-related macular degeneration. The lipofusion component N-retinyl-N-retinylidene ethanolamine detaches proapoptotic proteins from mitochondria and induces apoptosis in mammalian retinal pigment epithelial cells. J Bio Chem 2000; 275: 39625–39630, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ditaranto-Desimone K, Saito M, Tekirian T L, et al. Neuronal endosomal/lysosomal membrane destabilization activates caspases and induces abnormal accumulation of the lipid secondary messenger, ceramide. Brain Res Bull. 2003; 59: 523–531, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Nixon R A, Cataldo A M, Paskevich P A, et al. The lysosomal system in neurons. Involvement at multiple stages of Alzheimer's disease pathogenesis. Ann N Y Acad Sci 1992; 674: 65–88, [CSA]
   PubMed Web of Science ®Google Scholar
• Ward D M, Griffiths G M, Stinchcombe J C, Kaplan J. Analysis of the lysosomal storage disease Chediak-Higashi syndrome. Traffic. 2000; 1: 816–822, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Manganelli P, Fietta P. Apoptosis and Sjögren's syndrome. Sem Arthritis Rheum. 2003; 33: 49–65, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Corrons F J, Camihort G A, Gomez Dumm C L, et al. Structure and ultrastructure of the endocrine pancreas in diabetic transgenic mice. Medicina. 1996; 56: 666–670, [CSA]
   PubMed Web of Science ®Google Scholar
• Miyagawa J I, Hanafusa T, Miyazaki A, et al. Ultrastructural and immunocytochemical aspects of lymphocytic submandibulitis in the non-obese diabetic (NOD) mouse. Virchow Arch Cell Pathol. 1986; 51: 215–225, [CSA]
   Google Scholar